Navigation Links
Global Biosimilars: A return to optimism?
Date:12/12/2012

o appear, and in May 2011 FDA published details for User Fees – a scheme that will not come into effect
(assuming it is passed by Congress) until 2013. Given that an untried regulatory system will not operate at the fastest speed then prospects of a US market for advanced biosimilars seem remote before 2015. In contrast, European regulators are revising their widely-adopted regulations in the light of experience, with a view to issuing revisions and guidance in 2012.




Developing markets may offer a profitable alternative
Developing markets with rising disposable incomes may present the medium-term prospect for biosimilars, since they combine a large target population with reduced operating costs. Many countries are following the EU model of regulation. Markets such as India and China have plenty of home-grown production capacity. Some companies
have sought to turn this capacity to their advantage, and have signed deals with Chinese/Indian producers for the development of products to be sold around the world.




This report provides a comprehensive insight to the market environment,
current and future products and the companies involved.
A complete examination of the regulatory situation in the US, Europe and emerging markets
Detailed assessment of current biosimilar products and developers with market share by product
- EPO
- G-CSF
- HGH
- Human Insulin
- Interferon (alfa & beta)
Identification and analysis of likely second wave of advanced biologics to come to the market
- Adalimumab
- Etanercept
- Infliximab
- Rituximab
- Trastuzumab



A review of operational issues that will affect the adoption of biosimilars including pricing/reimbursement, clinician attitudes and patient acceptance
The position, activity, products, pipeline and plans of 50 leading players in the field


The Challenge for Industry
The dev
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. ... management will participate in the Deutsche Bank Health Care ... Boston Waterfront Hotel.  Mr. Adrian Adams ... present an overview of the Company and its product ... 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... China , announced that Sinovac Beijing, ... the Certificate of Good Manufacturing Practices for Pharmaceutical ... Food Administration (CFDA) for its proprietary vaccines, its ... filing and packaging facility. The GMP certificate covers ...
(Date:5/24/2013)... England and BOSTON , May ... drug discovery and development company, is pleased to announce that it ... Consultant to augment the Company,s business development capabilities in ... has more than 15 years of experience in business development, licensing ... Perlegen Sciences, Inc., Roche Pharma ( Japan ), Nippon ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Bleeding in Patients Treated for Acute Coronary Syndromes,(ACS) ... Year, NEW ORLEANS, March 26, 2007 /PRNewswire/ -- ... acute coronary syndrome,(ACS) patients in the "Angiomax(R) (bivalirudin) ... outcomes compared with,more complicated standard therapy, confirming previous ...
... 2 Findings Suggest Improved Outcomes in Carotid,Artery ... /PRNewswire-FirstCall/ --,Positive 30-day results from two Abbott ... with positive results by,physicians with a variety ... in patients who are not favorable,candidates for ...
Cached Medicine Technology:Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4
(Date:5/25/2013)... Plains, NJ (PRWEB) May 25, 2013 ... iPhone. The universal app version of Word Hunt ... app versions of Concentration, Edge Match, Flash 2, Sudoku and ... , The brain games’ gameplay and revolutionary lifetime brain fitness ... 4 inch displays. , “100 years of brain fitness measurement ...
(Date:5/25/2013)... Los Angeles, CA (PRWEB) May 25, 2013 ... will grow at an average annual rate of 28.7% ... growth of 17.9% in 2013. From 2002 and 2008, no ... analyst Kevin Culbert, causing relatively modest growth during that period. ... (FDA) has approved six new products. This factor contributed to ...
(Date:5/25/2013)... Texas (PRWEB) May 25, 2013 ... stressful than finals week. Increasingly, they are turning ... stay awake and study. For more on this, ... a drug treatment facility, warns that students who ... finals” are at risk for developing a physical ...
(Date:5/25/2013)... 2013 Ayurveda is the traditional ... or wisdom of life". While a medical science, its scope ... of consciousness. Its fundamental philosophy is that disease is the ... It believes that in order to re-establish optimal health, we ... then adopt a life style which brings us back into ...
(Date:5/25/2013)... May 25, 2013 The current residents of ... parents, and the B2B staff all came together Saturday, May ... an array of Indian Cuisine, the residents got up to ... helping them on their road to recovery, and giving them ... and Alcohol center in 2010 after realizing the need for ...
Breaking Medicine News(10 mins):Health News:Acuity Games Apps Come to the iPhone 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2
... more sensitive to early signs of Alzheimer,s dementia than ... School of Medicine in St. Louis. Doctors often ... testing them with a variety of cognitive tasks, such ... of objects. Washington University researchers developed a different approach. ...
... By Randy Dotinga HealthDay Reporter , MONDAY, Sept. ... the devastation suffered by men when their wives or girlfriends ... were almost 40 percent more likely than other men to ... risk of hospitalization among the men was very small, and ...
... Inc. is presenting new data in five posters and ... the company,s radioprotectant Ex-RAD at the 56th Annual Meeting ... Maui, Hawaii. In vivo studies show that Ex-RAD, ... versus placebo-treated groups in mice exposed to lethal whole ...
... best practice and endorsement of evidence-based medicine, the American ... and released a clinical practice guideline, which found a ... a way to treat fractures in the spine. ... to ensure that patients receive high quality care. ...
... and military efforts continuing in Afghanistan, UCLA has helped ... forces medical personnel in critical combat casualty care. The ... program,s developers say, but civilian care as well. ... the field during Operation Iraqi Freedom and Operation Enduring ...
... first studies to focus exclusively on the outcomes ... http://www.mayoclinic.org/prostate-cancer/ ) researchers have found that surgery provides ... and Fox Chase Cancer Center ( http://www.fccc.edu/ ) ... aggressive forms of prostate cancer who had radical ...
Cached Medicine News:Health News:Friends, family detect early Alzheimer's signs better than traditional tests 2Health News:Friends, family detect early Alzheimer's signs better than traditional tests 3Health News:Male Partners of Breast Cancer Patients May Suffer Depression 2Health News:Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting 2Health News:Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting 3Health News:New guideline finds no evidence for a popular back procedure 2Health News:New guideline finds no evidence for a popular back procedure 3Health News:UCLA develops combat casualty care educational program for US armed forces 2Health News:UCLA develops combat casualty care educational program for US armed forces 3Health News:Surgery found effective for patients with aggressive prostate cancer 2
... for a complete line of diagnostic coronary ... with the quality, reliability and precise performance ... in catheter technology. All of our coronary ... to help minimize the frustration and excess ...
The Polaris-DX steerable diagnostic catheter is designed for comfort and ergonomic handling during mapping procedures....
... of the PARAHISIAN catheter, combines an octapolar ... permits the use of only one catheter ... His bundle electrograms. The "two catheters in ... a single venipuncture. The disadvantages of using ...
... HIS diagnostic catheters provide the ... curve that allows for placement ... bundle. In addition, the soft ... the risk of perforation while ...
Medicine Products: